Back

Hemodynamic effects of vericiguat in symptomaticHFrEF patients: insights from right heart catheterization study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Optimisation of heart failure treatment Haemodynamics of Heart Failure ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Hideaki Suzuki

Tohoku University Hospital, Sendai (Japan)

8 More presentations in this session

Presentation thumbnail
Up-titration of Guideline Directed Medical Therapy (GDMT) and the occurrence of side effects in Heart Failure with reduced Ejection Fraction (HFrEF)
Doctor N. Panagiotides (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Visit-to-visit changes in heart rate in heart failure: a pooled participant-level analysis of the PARADIGM-HF and PARAGON-HF trials
Doctor H. Lu (Lausanne, CH)
Abstract Slides Video
Presentation thumbnail
Use and associations with mortality/morbidity of guideline-directed medical therapy use in heart failure with improved ejection fraction: a PS-matched analysis from the swedish heart failure registry
Doctor C. Basile (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
SGLT2 inhibitors are associated with development of heart failure with improved ejection fraction
Doctor X. Wang (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Survival benefit of guideline-directed medical therapy in elderly patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis
Doctor E. Tan (Singapore, SG)
Abstract Slides Video

Access the full session

Session thumbnail
Optimisation of heart failure treatment

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Non-invasive bioimpedance analysis predicts NT-proBNP changes during hospitalization in a cohort of acutely decompensated heart failure patients
thumbnail
Congress Presentation
Vericiguat in a real-world heart failure population: a single-centre experience
thumbnail
Congress Presentation
Effect of guideline-recommended medical therapy according to blood urea nitrogen

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources